HSA & FSA accepted; best-value for top quality care
Same-day mental health, weight loss, and primary care appointments available
Accept major insurances and cash-payHSA & FSA accepted; best-value for top quality careSame-day mental health, weight loss, and primary care appointments availableAccept major insurances and cash-pay
Ibrance is an FDA-approved oral treatment used in combination with hormone therapy for hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer in adults.
Interested in getting evaluated for an Ibrance prescription online? Connect with a licensed provider through Klarity Health and receive care in as little as 24 hours.* Providers will assess your symptoms and determine if Ibrance or another treatment is appropriate.
Providers on Klarity Health are independent practitioners with clinical autonomy; a diagnosis, treatment, or prescription is not guaranteed.
Providers on Klarity Health are independent practitioners with clinical autonomy; a diagnosis, treatment, or prescription is not guaranteed.
You’re unique. And your needs are too. You deserve advanced breast cancer treatment from a provider committed to you. That’s why you can find an advanced breast cancer specialist on Klarity Health and access:
From an experienced, board-certified healthcare professional.
or in-person through treatment tailored to you**
Your information is private, secure, and 100% HIPAA compliant.
*Your provider will discuss treatment options with you, which may or may not include medication.
Klarity Health connects you with experienced, licensed providers who specialize in the treatment of advanced breast cancer. Select your state to see available providers.
Getting started with an Ibrance prescription online involves these steps:
Ibrance is one of several CDK4/6 inhibitors. Below is a comparison with Kisqali and Verzenio:
| Medication | Dosing Schedule | Key Side Effects | Notes |
| Ibrance (palbociclib) | 21 days on / 7 off | Neutropenia, diarrhea, fatigue | Approved in 2015; requires routine bloodwork |
| Kisqali (ribociclib) | 21 days on / 7 off | Neutropenia, QT prolongation | Requires ECG monitoring |
| Verzenio (abemaciclib) | Continuous, twice daily | Diarrhea, fatigue | Lower neutropenia risk; more GI side effects |
Your provider will consider your health history, side effect tolerance, and monitoring needs when recommending a specific CDK4/6 inhibitor.
Read through stories from real patients who received treatment from healthcare providers on Klarity.
*Appointments are generally available within 24 hours. Free initial consultations are available only with select providers. Prescriptions, particularly for controlled substances, may require an in-person evaluation depending on the state of residence and current federal regulations.
The information provided in this article is for educational purposes only and should not be construed as medical advice. Always seek the guidance of a qualified healthcare professional with any questions or concerns you have regarding your health. Providers on Klarity Health are independent practitioners with clinical autonomy. Nothing in this article is intended to diagnose or treat any condition, including guaranteeing prescription medication of any kind or dosage. Not all providers on Klarity Health prescribe all medications, particularly medications that are controlled substances.
PO Box 5098 Redwood City, CA 94063
100 Broadway Street, Redwood City CA, 94063
Join our mailing list for exclusive healthcare updates and tips.
PO Box 5098 Redwood City, CA 94063
100 Broadway Street, Redwood City CA, 94063
